Getinge's subsidiary Maquet Cardiovascular receives adverse jury trial verdict in patent infringement dispute with Abiomed in the U.S.

A jury in the US District Court for Massachusetts ruled in favor of Abiomed against Getinge subsidiary Maquet Cardiovascular in a patent infringement dispute. The jury found Abiomed's Impella percutaneous ventricular assist device does not infringe Maquet's intravascular heart pump patents. This verdict covers one of two ongoing patent cases between the companies. Maquet is evaluating options for appeal. Getinge states the verdict has no negative financial or operational impact.